| Pharmaceutical active ingredients: |
| GuaifenesinPhenylephrine HydrochloridePhenylpropanolamine |
| Available forms, composition and doses of Kisitex: |
| N / A |
| Kisitex medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA51 - Phenylpropanolamine, combinationsR01BA53 - Phenylephrine, combinationsR05CA03 - Guaifenesin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| A.J. Bart |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Simuc | Guaifenesin; Phenylephrine Hydrochloride | Cypress Pharmaceutical |
| Sinupan | Guaifenesin; Phenylephrine Hydrochloride | Ion Laboratories |
| SINUvent PE | Guaifenesin; Phenylephrine Hydrochloride | WE Pharmaceuticals |
| Triaminic Chest and Nasal Congestion | Guaifenesin; Phenylephrine Hydrochloride | Novartis |
| Xpect-PE | Guaifenesin; Phenylephrine Hydrochloride | Cypress Pharmaceutical |
| Banex | Guaifenesin; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride | Lu Chem Pharmaceuticals |
| Coldloc | Guaifenesin; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride | Fleming Pharmaceuticals |
| Contuss | Guaifenesin; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride | Parmed Pharmaceuticals |
| Cyntex | Guaifenesin; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride | Cypress Pharmaceutical |
| Dura-Gest | Guaifenesin; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride | Biovail Pharmaceuticals |